New targeted drug hopes to shrink Hard-to-Treat tumors
Disease control
Recruiting now
This study tests an experimental drug called JAB-30355 in adults with advanced solid tumors that have a specific mutation in the TP53 gene (Y220C). The goal is to see if the drug is safe, tolerable, and can shrink tumors. About 144 participants who have already tried at least one…
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC